ENDRA Life Sciences (NDRA) Revenue (2016 - 2018)

ENDRA Life Sciences (NDRA) has 3 years of Revenue data on file, last reported at $6174.0 in Q1 2018.

• Revenue for Q1 2018 came in at $6174.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $6174.0 (down 98.24% YoY), and the FY2018 annual result was $6174.0, down 98.24% from the prior year.
• Revenue eased to $6174.0 in Q1 2018 per NDRA's latest filing, from $6850.0 in the prior quarter.
• Over five years, Revenue peaked at $515582.0 in Q4 2016 and troughed at $6174.0 in Q1 2018.
• A 3-year average of $174675.6 and a median of $57772.0 in 2017 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 98.67% in 2017 and fell as far as 98.67% in 2017.
• A 3-year view of Revenue shows it stood at $515582.0 in 2016, then sank by 98.67% to $6850.0 in 2017, then decreased by 9.87% to $6174.0 in 2018.
• Business Quant data shows NDRA's Revenue at $6174.0 in Q1 2018, $6850.0 in Q4 2017, and $287000.0 in Q3 2017.